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Membrane fusion is a fundamental requirement in numerous developmental, physiological, and pathological
processes in eukaryotes. So far, only a limited number of viral and cellular fusogens, proteins that fuse mem-
branes, have been isolated and characterized. Despite the diversity in structures and functions of known fus-
ogens, some common principles of action apply to all fusion reactions. These can serve as guidelines in the
search for new fusogens, and may allow the formulation of a cross-species, unified theory to explain diver-
gent and convergent evolutionary principles of membrane fusion.Introduction
The basic building blocks of all organisms are cells, whose outer
surfaces are lipid bilayer-based plasmamembranes. The plasma
membrane normally functions as a barrier between the inner
contents of individual cells and between the cells and the extra-
cellular space. This compartmentalization by membranes allows
cells to function as single units with discrete genetic and bio-
chemical programs. However, in various biological processes,
these compartments must be extended as cells unite to form
syncytial tissues where internal contents are mixed. Although
such cell union might in principle proceed through phagocytosis
followed by membrane breakdown, many examples of syncytio-
genesis involve fusion between plasma membranes of individual
cells. In prokaryotes, it is not known whether membrane fusion
occurs in processes where two bacteria are united; for example,
during conjugation. The fusion of mitochondria from prokaryotic
origin, however, raises the possibility that cell fusion does occur
in some prokaryotes. In contrast, cell fusion has been identified
as an important stage of development in most eukaryotes from
yeast to humans. Characterized examples include gamete fusion
in protists, fungi, plants, and animals; hypodermis (epidermis)
formation in Caenorhabditis elegans; muscle organogenesis in
Drosophila melanogaster and vertebrates; and bone and pla-
centa organogenesis in mammals. In these processes, cell
fusion is used to unite gametes and other cells, to alter cell differ-
entiation states, and to resculpt organs. In addition to its occur-
rence in normal physiology, membrane fusion is essential for the
progression of different pathological events such as viral entry
into host cells and, possibly, tumor progression.
Despite the diversity in the organisms and cell types that uti-
lize cell fusion in normal physiology and pathology, most fusion
reactions occur via a common stereotypic sequence of events
starting with cell-cell recognition, alignment, and adhesion.
This is followed by an actual fusion event that merges the two
cells together by the tethering of plasma-membranes, formation
of aqueous pores between the membranes, and expansion of
these pores to clear the membranes from the fusing cells’ junc-
tion. The diversity of cell fusion stages suggests the sequential
activity of various proteins executing different biological pro-cesses that in sum account for cell fusion. Although much is
known about several fusion stages within a specific model or-
ganism, the field of cell fusion lacks a cross-species, unified pic-
ture of the molecular mechanisms of this multistep process
(Chen et al., 2007; Chen and Olson, 2005; Oren-Suissa and Pod-
bilewicz, 2007; Shemer and Podbilewicz, 2003).
The Fusogen Concept versus Spontaneous Fusion
In vitro experiments have revealed that in the absence of pro-
teins, fusion between lipid bilayers mimicking the typical compo-
sition of biological membranes requires energy input. As a result,
even close and long-lived contacts between membranes under
physiological conditions do not yield fusion (reviewed in Cherno-
mordik et al., 2006). Thus, membrane fusion is widely assumed
to be controlled by, and to rely on, the activity of fusogenic pro-
teins that lower the energy barrier of the process and drive mem-
brane bilayer rearrangements that result in membrane and cell
merging (Chernomordik et al., 2006; Jahn et al., 2003). Theoret-
ically, any of the biological fusion reactions for which no special-
ized fusogen has been identified may represent a hypothetical
‘‘spontaneous’’ fusion (Kerbel et al., 1983) dependent on desta-
bilization of membrane bilayers caused by changes in their com-
position, and by proteins that normally carry out fusion-unrelated
functions (Byrne et al., 2007; Lemaire et al., 2006; Palovuori and
Eskelinen, 2000). However, all well-characterized biological
fusion events studied so far have been found to rely on the ac-
tivity of specialized fusogens that directly fuse lipid bilayers
(Chernomordik et al., 2006; Jahn et al., 2003).
Because enveloped viruses contain only a small number of
proteins and have developed rather simple fusion machineries
relying, in many cases, on the activity of one fusogenic protein,
identification of viral fusogens is relatively easy. In contrast, val-
idation of a candidate eukaryotic cellular protein as a ‘‘true’’ de-
velopmental fusogen in vivo is not a trivial task. Many candidate
proteins have been proposed to act as developmental fusogens,
yet only a fraction of these proteins have proven to be actual fus-
ogens (reviewed in Oren-Suissa and Podbilewicz, 2007). A bona
fide fusogen has to satisfy several criteria, such as being neces-
sary for cell fusion and localizing to the fusion site. Final valida-
tion stems from fusogen sufficiency to directly mediate fusionDevelopmental Cell 14, January 2008 ª2008 Elsevier Inc. 11
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a candidate fusion protein is a major challenge in identifying the
missing developmental fusogens, which is a crucial step in deci-
phering the molecular basis of cell fusion during development
(Oren-Suissa and Podbilewicz, 2007).
In this review, we discuss the pathway and molecular mecha-
nisms of membrane fusion, beginning from fusion of viruses with
cells of infected hosts. Emerging mechanisms of viral fusion will
be the basis of comparison with the less-characterized and likely
more complex process of cell fusion in eukaryotes. We will focus
on the proteins that drive membrane rearrangements in the tran-
sition from membrane tethering to opening and expansion of
fusion pores, a process that lies at the heart of cell fusion (Fig-
ure 1). To avoid mechanistic misinterpretations derived from
emphasis on candidate fusogens that might not participate in
the membrane fusion process per se, we will restrict our review
to the selected group of fusogens that have been shown to
directly fuse heterologous cells (Figure 1). We will discuss both
similarities and differences in the structures and activities of
the different fusogens, emphasizing the constraints and flexibility
of the molecular mechanisms leading to cell fusion.
Conserved Rearrangements of Membrane
Phospholipids during Fusion
Theoretical and experimental studies of membrane intermedi-
ates in diverse fusion reactions revealed a common membrane
remodeling pathway apparently conserved in all membrane-
fusion events, including exocytosis, protein trafficking, and viral
and developmental cell fusion (Chernomordik and Kozlov, 2005;
Chernomordik et al., 1993; Nakatogawa et al., 2007; Xu et al.,
2005; Podbilewicz et al., 2006). One workingmodel for themerg-
ing of biological membranes involves four simple steps: (1) Two
opposed biological membranes are separated by 10–20 nm. (2)
The membranes undergo deformations, causing a local ap-
proach. (3) The reaction proceeds via a stereotypic membrane
lipid rearrangement, called hemifusion. In this step the outer leaf-
lets, which face each other through an intermembrane 3–5 nm
water gap, are the first to fuse, and proceed to mix their lipids.
In contrast, the inner leaflets remain separated, preventing the
mixing of aqueous contents (Chernomordik et al., 2006). (4) Sub-
sequent merger of the inner leaflets marks the transition from
a hemifusion intermediate to a fusion pore and contents mixing
(Figure 1). Current understanding of the molecular mechanisms
by which proteins fuse membranes is, to a large extent, based
on the work on viral fusion.
Fusion Mediated by Diverse Viral Proteins
The entry of numerous enveloped viruses, including many
human pathogens, into the host cell relies on fusion between
the viral and the host cell membranes. In addition to viral-host
membrane fusion, some viral fusogens mediate fusion between
virus-infected cells and adjacent noninfected cells. The large
numbers of organisms and cell types targeted by different vi-
ruses necessitate a diversity of both structure and function of
the fusogenic arsenal. However, from the growing repertoire of
enveloped viruses, only a few have been studied in depth as par-
adigms of virus-host cell fusion (Kielian and Rey, 2006).
In general, enveloped viruses invade cells by a pathway that
involves binding of the viral particle to receptors at the host12 Developmental Cell 14, January 2008 ª2008 Elsevier Inc.cell surface. Diverse triggers activate specific viral envelope gly-
coproteins that serve as fusogens. Activated fusogens fuse the
viral envelope with either plasma or endosomal membranes,
delivering the viral genome into the cytoplasm of the host cells.
Various Triggering Mechanisms
Control Virus-Host Cell Membrane Fusion
Most viral fusogens are organized as homo- or hetero-oligomeric
complexes comprising one (e.g., influenza; Earp et al., 2005;
White, 1992) or up to four (e.g., herpes simplex; Subramanian
and Geraghty, 2007) types of transmembrane envelope glyco-
proteins. Premature activation of the fusogen and incorrect
fusion are suppressed either by the position of the fusogenic
domains that are buried inside the protein, or by inhibitory inter-
actions with peripheral subunits or accessory proteins. At the
onset of fusion, these interactions are released to allow confor-
mational changes of the proteins toward their fusogenic forms.
Fusogen activation can be triggered by virus interaction with
cell-surface receptors at neutral pH (e.g., HIV), or by virus inter-
nalization and exposure to mildly acidic pH along the endocytic
pathway (e.g., influenza virus) (Earp et al., 2005). Alternatively,
activation can occur via sequential receptor interactions and
acidification, as in avian sarcoma and leukosis virus (Mothes
et al., 2000). In the case of Ebola virus (Chandran et al., 2005)
and SARS-coronavirus (Simmons et al., 2005), receptor binding
induces conformational changes that allow cathepsin-mediated
proteolysis within acidic endosomes, releasing fusogenic poly-
peptide fragments. In conclusion, the timing and location of
virus-cell fusion is controlled by diverse mechanisms of fusogen
activation that prevent premature nonproductive launching of
the fusion machinery.
Structures and Mechanisms of Viral Fusogens
Crystallographical studies of protein fusogens from enveloped
viruseshave revealedmanydivergent structuralmotifs.However,
thesestudiesalsouncoveredastrikingly conservedhairpin struc-
ture of the postfusion conformations of viral fusogens, wherein
theirmembrane-interacting amphiphilic peptide regions, referred
to as fusion peptides, are positioned at the same end of rod-
likemolecules as the transmembranedomains. It is hypothesized
that under fusion conditions, the viral fusogens first establish
an extended conformation that delivers a bundle of exposed
fusion peptides to the host cell membrane (Figures 1A–1C). Sub-
sequent protein refolding into the final hairpin structure clamps
the two membranes.
On the basis of their prefusion and postfusion structures, viral
fusogens have been divided into several classes (Kielian and
Rey, 2006; Weissenhorn et al., 2007).
Class I fusogens include hemagglutinins from orthomyxovi-
ruses (e.g., influenza A, B, and C), F proteins from paramyxovi-
ruses (e.g., parainfluenza viruses, measles virus, etc), ENV
proteins from retroviruses, and fusogens of filoviruses and coro-
naviruses. Each class I protein is initially synthesized as an im-
mature precursor that is proteolitically processed into two poly-
peptides. Ectodomains of at least some of these fusogens (e.g.,
influenza A hemagglutinin [HA] and HIV ENV) are organized in
homotrimers that are probably oriented perpendicularly to the
envelope surface. Fusion appears to require the concerted
action of several HA trimers (Danieli et al., 1996; Kanaseki
et al., 1997; Markovic et al., 2001; Yang et al., 2005). In contrast,
fusion of HIV might require just a single ENV trimer (Yang et al.,
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Fusogens are drawn embedded in themembranes after the stages of oligomerization, sorting, trafficking, and binding to the host receptors (not shown). a helices,
light and dark blue cylinders; transmembrane domains, dark green; fusion peptides or loops, orange; b sheets, light green ellipses.
(A) Class I viral fusogens (such as in HIV) contain two a helices and an amphiphilic fusion peptide buried inside the protein in the prefusion state. Upon activation,
the trimers undergo a conformational change leading to the formation of rigid coiled-coil structures with exposed fusion peptides at their N termini. Insertion of
fusion peptides into the host membrane, concomitant with protein fold back into six-helix bundles, leads tomembrane tightening, hemifusion, and pore formation
(Kielian and Rey, 2006).
(B) In Class II viral fusogens (for example, in Dengue viruses), hydrophobic fusion loops emanate from a structure containing b sheets. After fusogen activation and
a shift from heterodimers to homotrimers (not shown), the fusion loops are exposed and inserted into the opposing membrane. Folding back occurs presumably
by interaction between different domains of the protein that drive membrane fusion (Kielian and Rey, 2006).
(C) Class III fusogens (such as in Rabies and VSV viruses) combine characteristics of Class I and II including short and discontinuous hydrophobic fusion loops
that stem from a structure containing b sheets, and a helices that potentially form six-helix bundles to merge the membranes together. In contrast to class I and II
fusogens, activation does not require fusion domain exposure (Heldwein et al., 2006; Weissenhorn et al., 2007).
(D) SNARE-dependent intracellular fusion. Three different t-SNAREs, each with a single a helix domain, are bundled to form the target complex. This complex
binds a single a helix of v-SNARE that emanates from the vesicle membrane. Transition between loose and tight t- SNARE-v-SNARE complexes is mediated by
SNARE zippering and tethering of the membranes, leading to their fusion (Jahn and Scheller, 2006).
(E) Hypothetical model of FF fusion. The extracellular domains of FF proteins (C. elegans EFF-1 and AFF-1 proteins) are comprised of juxta-membrane hypothet-
ical globular domains (brown ellipses) and a putative cysteine-rich conserved domain that presumably forms an S-S based structure (in blue). Part of these
predicted extracellular loops are reminiscent of TGF-b receptor-like domains (in red). We hypothesize that cis-dimerization of FF molecules is followed by
homotypic trans-binding between dimmers. Trans-zippering of FF complexes from the two membranes induces membrane tightening, hemifusion, and fusion
pore formation.2005). In the initial prefusion state, each trimer contains con-
served fusion peptides, which are buried inside the trimeric com-
plex. Activation induces a conformational change resulting in theformation of extended a-helical coiled-coil domains that are
thought to insert the fusion peptides into the opposing mem-
brane. In the final postfusion conformation, a six-helix bundleDevelopmental Cell 14, January 2008 ª2008 Elsevier Inc. 13
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transmembrane domains and fusion peptides at the same fused
membrane (Figure 1A).
Class II fusogens include fusion proteins of alpha- and flavivi-
ruses that lack any clear sequence homologies but have strik-
ingly similar structures both in prefusion and postfusion states.
In their prefusion conformation, these homodimeric or heterodi-
meric glycoproteins lie tangentially (parallel) to the virus envelope
and have ‘‘internal’’ rather than ‘‘terminal’’ fusion peptides.
These fusogens have b strands and lack any coiled-coil do-
mains. In the postfusion conformation, the proteins form homo-
trimers of b-structured hairpins with the fusion peptide loops
and the C-terminal membrane anchors positioned at the same
end of the molecule (Figure 1B). Several class II fusogens are or-
ganized in complexes and networks that appear to play a role
during the fusion process (Gibbons et al., 2003, 2004).
Fusion proteins of rhabdoviruses and herpesviruses combine
some of the characteristic features of class I and class II proteins
and, thus, might represent a class III family of viral fusogens
(Roche et al., 2006, 2007; Kielian and Rey, 2006; Weissenhorn
et al., 2007). These proteins harbor both a helices, which pre-
sumably form a six-helix bundle to fold back the protein as
with class I viral fusogens, and an elongated b sheet structure
with an amphiphilic fusion peptide at its end, reminiscent of class
II viral fusogens. In contrast to class I and II proteins, this fusion
peptide is very short—just a few hydrophobic amino acid resi-
dues—and is discontinuous. For example, in the prefusion con-
formation of vesicular stomatitis virus (VSV) envelope protein G,
a bipartite fusion domain is exposed rather than hidden at an
oligomeric interface. In both prefusion and postfusion conforma-
tions, the membrane-interacting fusion domains and transmem-
brane domains are located at the same end of the homotrimeric
fusogen (Figure 1C). As with class I and II fusogens, class III
proteins form complexes made of several fusogenic proteins
that may have cooperative functions during membrane fusion
(Gaudin et al., 1996; Roche et al., 2007).
While the best-characterized protein fusogens discussed
above belong to enveloped viruses, some nonstructural proteins
of nonenveloped reoviruses are expressed at the plasma mem-
brane of infected cells and apparently promote dissemination of
the virus by fusing infected and noninfected cells. These fuso-
gens, referred to as fusion-associated small transmembrane
(FAST) proteins, have just 40 amino acid residues in the ectodo-
main, which includes a short and mildly hydrophobic domain
(Cheng et al., 2005; Shmulevitz et al., 2004; Shmulevitz and
Duncan, 2000). FAST proteins are much smaller than the ‘‘clas-
sical’’ fusogens of enveloped viruses, which are 150 to 300
amino acid residues long; they lack any extended heptad repeat
structures; and they do not appear to undergo major conforma-
tional changes under the conditions of fusion. FAST proteins rep-
resent an intriguing class of viral fusogens, and future exploration
of the mechanisms by which they fuse cell membranes will likely
broaden our understanding of cell fusion significantly.
Even for the best-characterized viral fusogens, the specific
mechanisms of action are yet to be identified. The convergence
of many viral fusogens with structurally diverse prefusion confor-
mations to a similar hairpin postfusion conformation is believed
to underlie a conserved principle of action (Kielian and Rey,
2006; Weissenhorn et al., 2007). According to several proposed14 Developmental Cell 14, January 2008 ª2008 Elsevier Inc.mechanisms, refolding of the fusogen into the final hairpin struc-
ture exerts a pulling force that bends membranes and, thus,
primes them for fusion (Bentz, 2000; Kozlov and Chernomordik,
1998; Weissenhorn et al., 1997). However, some findings seem
to disagree with these models. (1) Formation of a hairpin struc-
ture for class I fusogens can be separated from fusion since
the former either precedes (Borrego-Diaz et al., 2003; Park
et al., 2003) or follows (Markosyan et al., 2003, 2004) membrane
merger. (2) FAST proteins are unlikely to establish rigid hairpin
structures and also appear to be too short (1.5 nm) to reach
the target membrane through the 10–20 nm gap between
contacting membranes (Shmulevitz and Duncan, 2000). (3) The
pulling force that fusogens can apply to themembranes is limited
by the tightness of their membrane anchoring by fusion peptides.
If binding of the peptides to themembrane isweak, as in the case
of short and/or not very hydrophobic peptides, the force would
detach the anchors from the membrane before the membrane
bends. From this perspective, pulling membranes together by
VSV G likely requires a concerted action of multiple trimers
because the very short fusion peptide loops of this protein
(Roche et al., 2006) restrict the force that might be delivered by
each trimer.
Based on the conserved membrane rearrangements, the job
of the viral protein fusogen or fusogens includesmediating a local
approach between biological membranes, and then catalyzing
hemifusion and its transformation into a fusion pore (Figure 1).
Post-hemifusion stages of opening, and especially fusion pore
expansion, require more energy and a higher number of acti-
vated fusogens than hemifusion (Chernomordik and Kozlov,
2003; Cohen andMelikyan, 2004), and represent a point of no re-
turn in the process of cell fusion. It has been hypothesized that
these later stages in fusion might be driven by lateral membrane
tension generated by the assembly of multiple fusogenic mole-
cules into a relatively rigid interconnected protein coat around
the fusion site (Chernomordik and Kozlov, 2003; Kozlov and
Chernomordik, 2002; Leikina et al., 2004). The finding that fusion
proteins located outside the direct contact zone might be in-
volved in driving fusion pore expansion (Leikina et al., 2004;
Lenz et al., 2005) substantiates the hypothesis that this fusion
stage is driven by long-range membrane stresses.
It is also unclear whether fusion pore expansion at the later fu-
sion stages relies solely on the activity of the fusogens orwhether
other molecules are required. Candidate molecules that may
help in the membrane deformation process include force-gener-
ating cytoskeletal proteins, phospholipases, and proteins that
bend and disassemble membranes and junctional complexes.
We expect future work to emphasize the functional signifi-
cance of the fusion peptide-membrane interactions (Tamm,
2003) and lateral interactions between multiple fusogens (see
for review Chernomordik and Kozlov, 2003). In summary, while
the textbookmodels of viral-mediatedmembrane fusion are cur-
rently widely accepted (Figures 1A–1C), recent findings suggest
that these are just working models that will be modified or re-
placed as new molecular and structural details of the pathways
of viral-host cell membrane fusion are discovered.
Concluding Remarks on Viral Fusogens
Figures 1A–1C show the current consensusmodel for viral mem-
brane fusion. First, viral fusogens anchor the viral and host mem-
branes, and then fold back into hairpins to reduce the distance
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and transmembrane domains of diverse fusogens interact with
themembranes to initiate fusion. Diverse viral fusogens including
influenza virus HA (class I) (Chernomordik and Kozlov, 2003),
Sindbis virus E1 glycoprotein (class II) (Zaitseva et al., 2005),
Rabies G protein (class III) (Gaudin, 2000), and FAST proteins
(Top et al., 2005) are reported to catalyze fusion pore opening
through the hemifusion pathway. Third, lateral interactions be-
tween adjacent fusogens drive pore expansion (Chernomordik
and Kozlov, 2003). Because this pathway is controlled by the
elastic properties of membrane bilayers, many models converge
on the hypothesis that fusogens act by shaping the membranes
and generating elastic stresses that are released by hemifusion
and fusion (Kozlov and Chernomordik, 1998; Kuzmin et al.,
2001; Martens et al., 2007; Zimmerberg et al., 2006).
From Pathology to Physiology: Syncytins’ Activities
in Placental Fusion
Various viral fusogens including HIV ENV and the FAST proteins
can promote fusion between an infected cell and naive neighbor-
ing cells. This cellular fusogenic activity of viral proteins is further
exemplified by the proposed role of Syncytin proteins in placen-
tal fusion. In the placenta of some, but not all, mammals, the fetal
cytotrophoblasts fuse to form continuous layers of multinucleate
syncytiotrophoblasts localized at the maternal-fetal interface
(Huppertz et al., 2006). Several lines of evidence tie cytotropho-
blast fusion in primates and some rodents with the activity of pro-
teins from endogenous retroviruses (ERVs) that were integrated
into their genomes during evolution. From the large pool of hu-
man ERV (HERV), which makes up 8% of the human genome
(de Parseval et al., 2003; Villesen et al., 2004), 16 HERV elements
have been shown to encode intact ENV proteins. Taking into
account the fusogenic activity of ENV proteins in retroviruses
(Figure 1A), these HERV ENV proteins are candidates for the
promotion of cell fusion in humans. mRNA or protein products
of three of these env genes (ENV-R, W, and FRD) are predomi-
nantly expressed in the placenta (de Parseval and Heidmann,
2005). Two of these, Syncytin-1 (encoded by the HER-W ele-
ment) and Syncytin-2 (encoded by HER-FRD), have been further
characterized. Antisense knockdown of syncytin-1 in primary
cytotrophoblasts that undergo fusion in culture results in fusion
attenuation, suggesting that Syncytin-1 accounts at least in
part for trophoblast cell fusion (Frendo et al., 2003). Syncytin-1
and -2 forced expression are sufficient to mediate cell fusion in
various heterologous cell types, including insect cells and lipo-
somes (Blaise et al., 2003; Blond et al., 2000; Mi et al., 2000),
indicating that Syncytin-1 and -2 act as bona fide fusogens.
Regulation on Syncytins’ Activities
In contrast to viral fusogens, there are only limited data on the
structure and function of Syncytins. These single transmem-
brane proteins harbor all the domains characteristic of class I
viral fusogens, including a potential amphiphilic fusion peptide,
and undergo maturation steps that are reminiscent of HIV ENV
(Blond et al., 1999; Cheynet et al., 2005). Sequence analysis
and partial structural data of Syncytin-1 and -2 have revealed
that they share structural domains with several class I viral fuso-
gens, strengthening the notion that these proteins originated
from these fusogens and may use similar mechanisms to pro-
mote fusion (Renard et al., 2005) (Figure 1A). However, it is notknown whether the fusogenic activity of Syncytins relies on dy-
namic conformational changes of these fusogens that are similar
to the proposed fusionmechanisms of class I viral fusogens. Fur-
thermore, the potential membrane remodeling effects of Syncy-
tins leading to the hemifusion membrane intermediate, pore for-
mation, and complete fusion have not yet been determined. As
with fusion mediated by their viral fusogen ancestors, fusion
mediated by Syncytin-1 and -2 is dependent on the binding of
these proteins to cell surface receptors. Syncytin-1 binds the
ASCT1 and ASCT2 receptors (Blond et al., 2000; Marin et al.,
2003), whereas the receptors of Syncytin-2 remain uncharacter-
ized (Blaise et al., 2003). An additional layer of regulation of the
fusogenic activities of these proteins is provided by their placen-
tal expression. Syncytin-2 expression is restricted to the cytotro-
phoblasts (Malassine et al., 2007), whereas Syncytin-1 is pre-
dominantly expressed in the cytotrophoblasts and syncytial
trophoblasts (Blond et al., 2000; Frendo et al., 2003; Mi et al.,
2000). Hence, placental activity of Syncytins emerged, presum-
ably, due to the organism’s transcriptional networks that con-
trol Syncytins’ expression. In contrast, viral tissue specificity is
regulated posttranscriptionally, and is determined primarily by
the distribution of appropriate receptors on target cells, and by
fusogen activation.
Evolution of Placental Cell Fusion: Why Do Some
Mammals Use Fusogens of Viral Origin to Mediate
Cellular Fusion?
Syncytins are a unique example of convergent evolution in which
two pairs of endogenous retroviral genes were independently in-
tegrated and adapted for placental function (Dupressoir et al.,
2005). In rodents, Syncytins appear to be limited to the Muridae
family, including the mouse, the gerbil, and the hamster (Dupres-
soir et al., 2005). Hence, Syncytin integration occurred after the
speciation of Muridae from other rodent families some 20 million
years ago (MYA). Similarly, the primate-specific distribution of
Syncytin-1 and -2 suggest that they integrated specifically into
the genome of the primate ancestor 20–40 MYA. Lack of Syncy-
tins in the genomes of other mammals demonstrates that the ex-
istence of these elements is not rooted in early stages of mam-
malian evolution, but rather that Syncytin integration occurred
independently after the speciation of rodents and primates dur-
ing later mammalian evolution.
Rodents that bear Syncytins in their genomes have placenta of
a three-layered structure, with one cellular and two syncytiotro-
phoblast layers (trichorial placenta), formed by extensive cell
fusion. In contrast the placentas of other rodents are simpler,
comprised of one cellular and one syncytiotrophoblast layer
(monochorial placenta) that require less fusion events. Similarly,
placentas of primates seem to be more complex than those of
related nonprimate mammals. This raises the possibility that
formation of the complex placentas of primates and these ro-
dents necessitates fast and efficient fusion. This may occur by
the preferential adoption of proficient viral-derived ENV fuso-
gens instead of other unidentified, possibly slower, endogenous
placental fusogens that act in other organisms. Although expres-
sion of Syncytins and other cellular env genes from additional
HERV elements is not restricted to cells of the placenta (de Par-
seval and Heidmann, 2005; Mi et al., 2000), the activities of these
genes cannot account for all fusion events in mammals. It ap-
pears that cellular env genes are not expressed in muscles andDevelopmental Cell 14, January 2008 ª2008 Elsevier Inc. 15
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these fusions rely on the activity of as yet unidentified fusogens.
Thus, nonplacental fusogens probably fuse cells via different
mechanisms, suggesting that even within a single organism
the mechanisms underlying cell fusion are diverse.
The FF Family: The First Eukaryotic
Developmental Cell-Cell Fusogens
Although cell fusion plays key roles in the development and
physiology of most eukaryotes, most developmental fusogens
are still unidentified. The nematode C. elegans has emerged as
a powerful system for the identification of missing fusogens
thanks to the combination of genetic screening with the advan-
tage of an invariant and completely characterized cell lineage,
enabling the dynamic study of cell fusion at a single-cell resolu-
tion within a living organism (Podbilewicz andWhite, 1994). Iden-
tifying and characterizing developmental fusogens of C. elegans
can shed light on the identity and fusion mechanism of other, still
elusive, eukaryotic fusogens. In the C. elegans hermaphrodite,
stereotypic fusion of about one-third of the 959 somatic cells
throughout development generates 44 syncytia essential for or-
ganogenesis of various organs such as the epidermis, the phar-
ynx, the uterus, the hymen, and the vulva (Podbilewicz, 2006).
Several genetic screens for somatic fusion failure (FF) pheno-
types have identified two genes that, when mutated, result in
specific FF phenotypes. One gene encodes the epithelial fusion
failure-1 (EFF-1) protein that is required for most cell fusion
events in the epidermis, pharynx, and vulva (Mohler et al.,
2002). The second gene encodes the anchor-cell fusion failure-1
(AFF-1) protein that is essential for specific fusion events leading
to the formation of small syncytia, such as fusion of the anchor
cell (AC) to specific uterine cells to form the nematode’s hymen,
and fusion of a subset of vulval cells resulting in the formation of
vulval rings vulA and vulD (Sapir et al., 2007).
Further analyses of eff-1 and aff-1 mutants using cell-junction
markers, plasma-membrane and cytoplasmic dyes, and trans-
mission electron microscopy (TEM) on eff-1 mutant worms
have demonstrated that the FF proteins EFF-1 and AFF-1 act
specifically and independently to account for most cell fusion
events in C. elegans (Gattegno et al., 2007; Mohler et al., 2002;
Podbilewicz et al., 2006; Sapir et al., 2007; Shemer and Podbile-
wicz, 2002; Shemer et al., 2004). The fusogenic activity of FF pro-
teins was finally demonstrated by the finding that their ectopic
expression is sufficient to fuse cells that normally do not fuse
in C. elegans (Shemer et al., 2004), and even more significantly,
by the fusion of heterologous insect cells in culture (Podbilewicz
et al., 2006; Sapir et al., 2007). Fusion of heterologous cells by FF
proteins in insect cells indicates that EFF-1 and AFF-1 are bona
fide fusogens and provides an experimental system to study the
mechanism of their fusogenic activity, analogous to the cell cul-
ture systems used successfully for many viral fusogens.
Structure of FF Proteins
The aff-1 gene encodes one single-pass transmembrane pro-
tein, whereas the eff-1 gene encodes, by alternative splicing,
two single-pass integral membrane proteins and two secreted
polypeptides. Experiments in insect cell culture have demon-
strated fusogenic activity for the transmembrane isoforms of
FF proteins, whereas the function of the secreted forms remains
uncharacterized (Podbilewicz et al., 2006; Sapir et al., 2007). Like16 Developmental Cell 14, January 2008 ª2008 Elsevier Inc.most viral fusogens, the transmembrane forms of FF proteins
possess an N-terminal signal sequence followed by a long extra-
cellular portion, a predicted transmembrane domain, and a short
intracellular tail. Sequence comparison of putative FF orthologs
in several nematode species has uncovered novel motifs that do
not exist in viral fusogens and might be critical for FF-mediated
fusion. A striking conservation in the position and number of all
16 cysteines in the extracellular portion of FF proteins from 17
different nematode species suggests that these proteins are
folded in a similar 3D structure that is essential for their fusogenic
activity (Figure 2; O.A. and B.P., unpublished data). Despite this
conservation in nematodes, there is only minor sequence simi-
larity of FFs to proteins from organisms outside the nematode
phylum (Sapir et al., 2007). Most prominent is the spacing and
position of nine extracellular cysteines defining a domain that
exhibits similarity to the TGF-b binding domain of the activin/
BMP/TGF-b type I receptor superfamily (Kirsch et al., 2000).
Because this domain in FF proteins lacks critical residues that
are essential for the binding of TGF-b ligands, it is unlikely that
FF proteins function as TGF-b receptors (Sapir et al., 2007).
This domain may emerge, however, as an interacting extracellu-
lar region conserved between nematode FF proteins and the
unidentified fusogens in other phyla (Podbilewicz et al., 2006;
Sapir et al., 2007).
Fusion Mechanism of FF Proteins
Fusogen distribution on the two opposing membranes is one of
the essential features of the FF fusion mechanism. Experiments
in vivo and in heterologous culture cells indicate that expression
of EFF-1 in only one of two bound cells is insufficient for fusion
(Podbilewicz et al., 2006), and similar observations were made
in vivo for AFF-1 (Sapir et al., 2007). The requirement for the
same fusogen to be present on both fusing membranes thus de-
fines a homotypic arrangement as a cornerstone of the FF fusion
mechanism, distinguishing it from the single-membrane localiza-
tion of viral and Syncytin fusogens (Figure 1; White, 2007). This
homotypic machinery of FF mediated fusion is somewhat remi-
niscent of soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE)-dependent intracellular membrane fu-
sion, which involves interactions among three different t-SNARE
proteins localized to the surface of the target membrane and one
v-SNARE protein on the opposing vesicle membrane (Bonifacino
and Glick, 2004; Cai et al., 2007; Jahn et al., 2003; Jahn and
Scheller, 2006). SNAREs contain domains consisting of a single
a-helical amphipathic bundle that is unstructured in the nonas-
sembled state (Figure 1D). SNARE interactions yield a hydropho-
bic helical core complex that is proposed to ‘‘zipper’’ the SNARE
motifs from their N-terminal ends toward their C-terminal
membrane anchors and, as a result, to clamp the membranes
together (Jahn and Scheller, 2006). In addition to their vesicle fu-
sion activity, SNARE proteins have the potential to fuse the
plasma membranes of neighboring cells, as elegantly demon-
strated in a system in which artificially engineered ‘‘flipped’’
SNAREs on the cell surface mediate hemifusion and complete
cell-cell fusion (Giraudo et al., 2005; Hu et al., 2003).
Despite the similar requirement of fusogen presence in both
fusing membranes, an essential distinction is that during
SNARE-dependent fusion, each of the two membranes contrib-
utes a different combination of SNARE proteins (Figure 1D), while
the same protein (e.g., EFF-1) is present on both membranes
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ReviewFigure 2. Conservation of Residues and Motifs in FF Proteins from Nematodes
(A) Phylogeny of nematode species used for the sequence alignment. Using BLAST, FF proteins were identified in 17 nematode species from different clades
(O.A. and B.P., unpublished data). We aligned Caenorhabditis elegans (Ce) FF proteins with putative homologs from Pristionchus pacificus (Ppa), estimated
to diverge 200 million years ago (MYA) (Gutierrez and Sommer, 2004), and with proteins from the remotest nematode wherein FF proteins have been identified
so far, the parasite Trichinella spiralis (Tsp) (divergence estimated more then 600 MYA; Mitreva and Jasmer, 2006).
(B) Extracellular domains of FF proteins without signal sequences were aligned using the Jalview software (Clamp et al., 2004). Conservation of cysteines (pink),
the LGWYR motifs, and partial conservation of prolines (yellow) suggests functional roles for these residues and motifs (Sapir et al., 2007). Color is shown in res-
idues of 100% conservation and gray in cases where 50% of the physicochemical properties are conserved (Livingstone and Barton, 1993). Accession numbers:
CeAFF-1: EF205023; CeEFF-1: C26D10.5 PpaFF-1: contig162.29; PpaFF-2: Contig735.1 P. pacificus california ‘‘Assembly Freeze 1.’’ TspFF-1: Contig1.317;
TspFF-2: Contig3.96 Trichinella spiralis-1.0-contigs.during FF-based fusion. Furthermore, there is no obvious long
a-helical coiled-coil domain in the ectodomain region of the FF
fusogens. It is possible that FF-mediated fusion occurs via a
zippering mechanism like that proposed for SNAREs that leads
to membrane conjunction and fusion (Figure 1E). However, this
zippering possibly relies on the folding of cysteine-based struc-
tures in the extracellular domain of FF proteins and not on
SNARE-like a-helical coiled-coil bundling. The novel homotypic
arrangement of the fusogens identified for FF proteins may
stem from the need for tight control on the execution of develop-
mental fusion events. For example, homotypic design can pre-
vent unregulated fusion at the edges of a multinucleate cell, al-
lowing better control of syncytium size and shape (Podbilewiczet al., 2006). This mechanistic aspect may serve as a general
theme in developmental cell fusion in multicellular organisms.
Are FF proteins the only fusogens inC. elegans? In the genome
ofC. elegans, there is only onemore gene that encodes a protein
with significant sequence similarity to the FF fusogens. Mutant
analyses suggest that this gene may have, if any, only redundant
functions in cell fusion. Importantly, eff-1 aff-1 double mutant
analysis revealed that sperm-egg fusion seems to be normally
executed in an FF-independent manner (Sapir et al., 2007).
This event is facilitated, presumably, by other unidentified fuso-
gens that may not share significant sequence similarity with the
FF fusogens; thus, sperm-egg fusion may occur by a completely
different mechanism.Developmental Cell 14, January 2008 ª2008 Elsevier Inc. 17
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Fusion via hemifusion emerges as a convergent point in the
membrane fusion mechanism of all the diverse viral fusogens
studied so far (Figure 1). The characteristic hemifusion pheno-
type, lipid mixing without content mixing, and fusion inhibition
by hemifusion-blocking lipid lysophosphatidylcholine (LPC)
(Chernomordik et al., 1993) were demonstrated for EFF-1 fusion
in culture, indicating that EFF-1 proteins also fuse membranes
via the hemifusion intermediate (Podbilewicz et al., 2006). The fu-
sion of mammalian muscle cells in culture is also inhibited by
LPC, suggesting a similar pathway of membrane rearrange-
ments induced by unidentified mammalian fusogens (Reporter
and Raveed, 1973; W.A. Mohler, personal communication).
In principle, different proteins might control distinct stages of
the multistep fusion-through-hemifusion pathway of develop-
mental fusion, with one protein to catalyze hemifusion, another
to open a fusion pore, and still another to drive pore expansion.
However, EFF-1 appears to control the entire pathway. As men-
tioned above, EFF-1 induces membrane rearrangement, leading
to a hemifusion intermediate. EFF-1 also opens initial fusion
pores, as evidenced by lack of cytoplasmic content mixing and
pore formation in loss-of-function eff-1 mutants. Finally, partial
activity of EFF-1 in temperature-sensitive mutant animals re-
sulted in formation of partially expanding pores of 50–100 nm
that fail to further expand (Gattegno et al., 2007; Shemer et al.,
2004). Thus, EFF-1 is required first to induce membrane hemifu-
sion at sites that are subsequently rearranged into membrane
pores, and second to expand these pores to fully disassemble
the contact junction to yield a syncytium (Gattegno et al., 2007;
Podbilewicz et al., 2006). The requirement of many more viral
glycoproteins for expansion of initial fusion pores (Chernomordik
and Kozlov, 2003) raises the possibility that additional proteins
are acting with EFF-1 to expand fusion pores. Recently, the
role of the actin-remodeling moleculesWASP andWIP inD.mel-
anogaster muscle fusion pore expansion has been proposed
(Massarwa et al., 2007) in parallel with a distinct role of these
molecules in prefusion vesicle exocytosis (Kim et al., 2007). It
is not known whether pore expansion in C. elegans relies solely
on EFF-1 activity or requires additional proteins (for example, the
C. elegans WIP and WASP orthologs).
Regulation of FF Fusion
In vivo studies have revealed that there is a strict correlation be-
tween the expression of FFmRNAs, induced in fusion-fated cells
shortly before fusion, and the occurrence of cell fusion. Tran-
scription factors from different families (e.g., homeobox, GATA,
Zn fingers, FOS-1) positively and negatively control FF protein
expression and hence FF-mediated fusion (Cassata et al.,
2005; Margalit et al., 2007; Sapir et al., 2007; Shemer and Pod-
bilewicz, 2002; Alper and Kenyon, 2001, 2002; Koh et al.,
2002; Koh and Rothman, 2001; Podbilewicz, 2006). In addition
to transcriptional control, posttranslational regulation of FF pro-
teins is suggested by their dynamic localization in the fusing
cells. In an elegant study, del Campo et al. (2005) showed that
EFF-1 is specifically and dynamically enriched at the contact
zone between two fusing cells in vivo. In addition, possible post-
translational modulators of FF fusion have been identified: fus-1,
which encodes a subunit of the Vacuolar-ATPase complex that
was proposed to function as a proton pump, represses EFF-1-
mediated fusion (Kontani et al., 2005). nsf-1, which encodes18 Developmental Cell 14, January 2008 ª2008 Elsevier Inc.the NEM-sensitive factor (NSF) that presumably functions in ves-
icle trafficking, may promote AFF-1-mediated fusion of the AC
(Choi et al., 2006). This possible connection between FUS-1
and NSF-1 proteins and FFs was not further elucidated. Cur-
rently, there is no indication that FF-mediated fusion is regulated
by conformational changes of these proteins like the trigger-
dependent restructuring of viral fusogens. Although this mode
of regulation might exist, it seems that transcriptional control
combined with dynamic subcellular localization of the proteins
might be a central mechanism to regulate and specify
FF-mediated cell fusion within the organism.
Conclusions and Future Directions
Based on the current review, we ask four general questions that
summarize what we know and what we still have to learn about
cell fusion.
How Do Viral Fusogens Fuse Membranes?
We still do not know the molecular mechanisms by which even
the best-characterized viral fusogens unite membranes. How-
ever, there are five principles that appear to be shared by most
of the studied viruses (Figure 1): First, the prefusion structures
of oligomeric viral glycoproteins are localized to one of the fusing
membranes (the virus). Second, fusion triggering involves pro-
cessing, receptor binding, exposure to low pH, or some combi-
nation thereof. Third, triggering elicits diverse conformational
changes involving coiled-coils and/or b sheets exposing and
inserting amphiphilic fusion domains into the opposing mem-
brane. Fourth, diverse viral fusogens establish remarkably simi-
lar hairpin rod-like structures. Fifth, hairpin formation, interac-
tions between the fusion domains and membranes, and, likely,
lateral protein-protein interactions drive membrane rearrange-
ments into a hemifusion intermediate followed by fusion pore
formation and expansion.
Can We Use the Motifs of Viral Fusogens
to Find Developmental Fusogens?
No; because of the diversity between the genuine fusogens at
the level of primary sequences, the 3D structures, the triggering
events, and the conformational changes during fusion, it appears
unlikely that structural motifs can be used as reliable earmarks of
a fusogen. Thus, the strategies used to find bona fide fusogens
need to be adapted to each developmental system.
How Similar Are the Mechanisms
of Viral and Developmental Fusion?
The structures of the fusogens, activation mechanisms, and
requirements in one or both membranes (homotypic/hetero-
typic) are very diverse. However, the membrane pathway of
fusion through hemifusion appears to be conserved between
all classes of viral, intracellular SNARE, and developmental FF
fusogens.
Will the Paradigms for FF and Syncytin Cell Fusion Help
to Identify and Characterize Fusogens for Gametes,
Myoblasts, Macrophages, and Trophoblasts?
Although the missing developmental fusogens may not be iden-
tified by sequence similarity with FFs or Syncytins, the discovery
and characterization of the homotypic FF and the heterotypic
Syncytin fusion mechanisms can serve as general guidelines
for the identification and characterization of missing develop-
mental fusogens. Syncytins may represent an intermediate tran-
sition from viral to developmental fusogens, combining a typical
Developmental Cell
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lation during development. Deciphering the evolution of the fu-
sion mechanism employed by Syncytins, and their role in vivo,
are two intriguing topics for future research. Sperm-egg fusion
may represent a heterotypic Syncytin-like fusion mechanism.
As with virus-host fusion, fertilization involves fusion between
heterotypic cells with different genetic programs.
FF proteins exhibit a different fusion mechanism, which relies
on homotypic interactions between FF proteins anchored on the
two opposing fusing membranes. We hypothesize that develop-
mental fusion in muscles and bones will be regulated mainly by
transcription, will require cooperativity of the fusogens, and will
rely on homotypic interactions to restrict syncytium boundaries.
One of the main challenges for the future is to find the missing
developmental fusogens and determine the conserved and di-
vergent mechanisms of cell membrane fusion.
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